M.R. Sertoli

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

Gino Santini, Luigi Salvagno, Pietro Leoni et al. · Journal of Clinical Oncology · 1998 · 207 citations

A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.

Pierfranco Conté, Milena Bruzzone, S. Chiara et al. · Journal of Clinical Oncology · 1986 · 157 citations

Surgical Oncology, Epithelial Ovarian Cancer, Cancer Management +18

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-α2b in metastatic melanoma

E. Bajetta, Michele Del Vecchio, P. Nova et al. · Annals of Oncology · 2006 · 113 citations

Multicenter Phase Iii, Medicine, Melanoma +8

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer

Andrea Ardizzoni, M. Venturini, M.R. Sertoli et al. · British Journal of Cancer · 1994 · 70 citations · Full text

Dose Intensity Increase, Breast Oncology, Medicine +8

Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.

M. Venturini, Paolo Bruzzi, Lucia Del Mastro et al. · Journal of Clinical Oncology · 1996 · 51 citations